1. Home
  2. DRCT vs PPCB Comparison

DRCT vs PPCB Comparison

Compare DRCT & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Direct Digital Holdings Inc.

DRCT

Direct Digital Holdings Inc.

HOLD

Current Price

$0.61

Market Cap

1.8M

Sector

Technology

ML Signal

HOLD

PPCB

Propanc Biopharma Inc.

HOLD

Current Price

$0.11

Market Cap

1.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRCT
PPCB
Founded
2018
2007
Country
United States
Australia
Employees
N/A
2
Industry
Computer Software: Programming Data Processing
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.8M
1.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
DRCT
PPCB
Price
$0.61
$0.11
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$8.00
N/A
AVG Volume (30 Days)
105.0K
6.3M
Earning Date
05-08-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$34,694,000.00
N/A
Revenue This Year
$5.42
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.04
$0.10
52 Week High
$6.04
$10.69

Technical Indicators

Market Signals
Indicator
DRCT
PPCB
Relative Strength Index (RSI) 34.94 42.85
Support Level $0.52 N/A
Resistance Level $0.79 $0.13
Average True Range (ATR) 0.08 0.02
MACD 0.01 0.00
Stochastic Oscillator 21.04 17.23

Price Performance

Historical Comparison
DRCT
PPCB

About DRCT Direct Digital Holdings Inc.

Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.

About PPCB Propanc Biopharma Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Share on Social Networks: